Renhe Pharmacy Co Ltd
Company Profile
Business description
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicines, raw materials, and health-related products, including oral solid dosage forms, oral liquid dosage forms, large-volume injections, small-volume injections, external washes, liniments, suppositories, ointments, and other dosage forms of pharmaceuticals and health-related products. The company's main products include: Renhe Kelike, Youkadan series, Fuyanjie series, Da Huo Luo capsules, Shanliang eye drops, Qinghuo capsules, and Zhengwei capsules.
Contact
No. 998 Honggu Middle Avenue, Greenland Central Plaza
18th Floor, Yuanchuang International, Zone B
Honggutan New District, Jiangxi Province
Nanchang330038
CHNT: +86 79183896755
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
4,923
Stocks News & Analysis
stocks
Pure-play data center share raises capital to fund AI demand
stocks
Chart of the Week: BHP’s growth story faces a reality check
stocks
3 best ASX growth stocks to buy for the long term
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,978.80 | 34.20 | -0.38% |
| CAC 40 | 8,339.91 | 37.95 | -0.45% |
| DAX 40 | 24,805.70 | 109.79 | -0.44% |
| Dow JONES (US) | 52,503.43 | 49.54 | -0.09% |
| FTSE 100 | 10,594.92 | 22.68 | 0.21% |
| HKSE | 24,562.24 | 446.36 | -1.78% |
| NASDAQ | 25,461.40 | 420.54 | -1.62% |
| Nikkei 225 | 64,141.12 | 2,694.42 | -4.03% |
| NZX 50 Index | 13,694.68 | 79.90 | 0.59% |
| S&P 500 | 7,475.59 | 58.18 | -0.77% |
| S&P/ASX 200 | 8,796.70 | 20.10 | -0.23% |
| SSE Composite Index | 3,764.15 | 118.26 | -3.05% |